Vyriad Is A Clinical Stage Biotechnology Company Based In Rochesterminnesotaspecializing In Targeted Genetic Therapies Using Engineered Virus Platformsfounded By Scientists From The Mayo Clinicthe Company Operates From A 12 000 Square Foot Facility That Includes Research Labsa Gmp Certified Manufacturing Siteand Infrastructure For Clinical Trial Support The Company Focuses On Developing Oncolytic Virotherapieswhich Are Engineered Viruses Designed To Selectively Target And Destroy Cancer Cellsthese Therapies Are Currently In Phase 1 2 Trials For Various Cancer Typesoften In Combination With Immune Oncology Drugsvyriad Also Works On In Vivo Gene Therapiesutilizing Viral Vector Systems For Direct Gene Deliveryand Gene Editing Applications Through Virus Based Delivery Mechanismsstrategic Collaborations With Regeneron And Novartis Enhance Their Development Effortsparticularly In Advancing Car T Cell Therapiesthe Company Is Actively Engaged In Clinical Trials And Continues To Expand Its Research Capabilities
No conferences found for this company.
| Company Name | Vyriad Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
